ADEBRELIMAB

Clinical trials for ADEBRELIMAB explained in plain language.

Never miss a new study

Get alerted when new ADEBRELIMAB trials appear

Sign up with your email to follow new studies for ADEBRELIMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New cocktail aims to make liver cancer operable

Disease control Terminated

This study tests a combination of chemotherapy, immunotherapy, and a targeted drug given directly into the liver's blood supply to shrink tumors in people with liver cancer that may be removable with surgery. The goal is to see if this approach can make surgery more effective and…

Matched conditions: ADEBRELIMAB

Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC

ADEBRELIMAB

Get alerted when new ADEBRELIMAB trials appear

New cocktail aims to make liver cancer operable